Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine 30 mg Extended-Release in Mild or Moderate Hypertension
NCT07448506Phase 3Completed
- Sponsor
- Laboratorios Richmond
- Start
- Jul 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifedipine GITS in essential hypertension, sponsored by Laboratorios Richmond. Started Jul 2024; status: completed.
02
Drugs
nifedipine GITS
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT07448506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448506.